about IPA

About IPA

The Indian Pharmaceutical Alliance (IPA) represents 24 leading research-based Indian pharmaceutical companies. IPA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Know more

Our Resources

  • Articles

    Covid-19 tests Indian pharma’s limits

    May 17, 2021

  • Articles

    Indian pharma cos welcome patent waivers on COVID vaccines, says tech transfer needed to scale up

    May 7, 2021

  • Position Papers

    IPA Submission – USTR Special 301 Report

    January 29, 2021

  • Position Papers

    IPA Employee Safety Initiatives Report

    January 25, 2021

  • External Studies and Reports

    Beyond Business – Contributions to Social Initiatives_IPA Samhita

    December 14, 2020

  • External Studies and Reports

    Dealing with the Coronavirus: Pharma Industry and Government Collaboration in India_IIM-A case study

    September 1, 2020

    Like Download
  • Presentations

    The Indian pharmaceutical industry and global market

    September 30, 2019

  • Presentations

    New International Healthcare Policies in Making Perspective from India – Warsaw

    June 13, 2019

Know more

Our Videos

  • April 7, 2021

    Mr. Sudarshan Jain shares his thoughts on ‘World Health Day’

    Click to Play
  • April 5, 2021

    IPA HR Leadership Series – Webinar on “Impact of Labour Codes on Rewards”

    Click to Play
  • March 18, 2021

    IPA Manufacturing and Quality Workshops: Webinar 6 – “Operational Excellence in Pharma”

    Click to Play
  • March 15, 2021

    6th IP Forum: CEO Panel Discussion: COVID-19 impact on Pharmaceutical Industry

    Click to Play
  • March 15, 2021

    6th IPF 2021: Panel discussion – Digitalisation/automation and artificial intelligence…

    Click to Play
  • March 15, 2021

    6th IP Forum: Day 3 – Session 12 on ‘Quality compliance culture & empowerment in the…

    Click to Play
  • March 15, 2021

    6th IP Forum: Day 3 – Session 11 by Dr. Ghada Haddad – Exec. Director, Merck & Co.

    Click to Play
  • March 15, 2021

    6th IP Forum: Day 2 – Session 10 on ‘Industry-Academia Collaboration’

    Click to Play
  • March 11, 2021

    6th IP Forum: Day 2 – Session 8 by Mr. Rajendra Kumar Das, Sun Pharma

    Click to Play
  • March 11, 2021

    6th IP Forum: Day 1 – Session 7 by Ms. Beata Stepniewska, Medicines for Europe

    Click to Play
  • March 11, 2021

    6th IP Forum: Day 2 – Session 6 by Mr. Koen Laenen, Medicines for Europe

    Click to Play